Global clinical trial CRO specializing in patient enrollment and on-time delivery
PSI is a 1,000+ person contract research organization operating clinical trials across 50+ countries, with particular strength in patient enrollment and feasibility assessment. The hiring velocity is accelerating across research (dominant department), healthcare, and data roles globally — a pattern consistent with expanding trial capacity. Active projects cluster around study activation, patient recruitment strategy, and regional infrastructure (APAC), while pain points center on recruitment efficiency and timeline management — core operational constraints for a CRO built on predictable delivery.
Notable leadership hires: Therapeutic Area Director, Clinical Project Lead, Marketing Director
PSI conducts full-service clinical trials for pharmaceutical sponsors across oncology, hematology, infectious diseases, and multiple sclerosis. The company operates in 50+ countries and is known for combining feasibility assessment rigor with patient enrollment capability to deliver studies on schedule. Therapeutic expertise spans Phase 2 and Phase 3 trials. The organization maintains high repeat client rates and low staff turnover, indicating strong operational reputation and employee retention.
SAS, Phoenix WinNonlin for pharmacokinetic modeling, CDISC ADaM standards, Microsoft 365 suite (Teams, SharePoint, Exchange), Azure cloud infrastructure, and Confluence for collaboration. Infrastructure runs on Hyper-V, Proxmox, and VMware with Active Directory and IAM for access control.
PSI has active hiring across 24 countries: United States, United Kingdom, Germany, France, Spain, Canada, Japan, China, Italy, Poland, Hungary, Czech Republic, Slovakia, Croatia, Bulgaria, Bosnia and Herzegovina, Estonia, Latvia, Greece, Brazil, Argentina, Chile, Colombia, and Thailand.
Other companies in the same industry, closest in size